Growth suppression by a p14ARF exon 1β adenovirus in human tumor cell lines of varying p53 and Rb status
- 11 September 2002
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 9 (10) , 830-839
- https://doi.org/10.1038/sj.cgt.7700505
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Tumor Suppression and Therapy Sensitization of Localized and Metastatic Breast Cancer by Adenovirus p53Human Gene Therapy, 2001
- Human ARF binds E2F1 and inhibits its transcriptional activityOncogene, 2001
- Human ARF protein interacts with Topoisomerase I and stimulates its activityOncogene, 2001
- Adenovirus-mediated transfer of p53 and p16INK4a results in pancreatic cancer regression in vitro and in vivoGene Therapy, 2001
- p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastomaOncogene, 2000
- Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localizationOncogene, 2000
- Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53The EMBO Journal, 1999
- Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 functionOncogene, 1997
- Expression of p16INK4aSuppresses the Unbounded and Anchorage-Independent Growth of a Glioblastoma Cell Line That Lacks p16INK4aBiochemical and Biophysical Research Communications, 1997
- Quantitative Angiogenesis in a Syngeneic Tumor Spheroid ModelMicrovascular Research, 1995